The role of CT10 regulation of kinase-like in cancer (Q38296676)

1 September 2017

1 reference

title

The role of CT10 regulation of kinase-like in cancer (English)

1 reference

1 September 2017

Chunmei Guo

1

1 reference

1 September 2017

Shuqing Liu

series ordinal

2

1 reference

1 September 2017

Ming-Zhong Sun

series ordinal

3

1 reference

1 September 2017

language of work or name

English

0 references

publication date

1 December 2014

1 reference

1 September 2017

1 reference

1 September 2017

volume

10

1 reference

1 September 2017

issue

16

1 reference

1 September 2017

page(s)

2687-2697

1 reference

Crk family adaptors-signalling complex formation and biological roles

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

CrkIII: a novel and biologically distinct member of the Crk family of adaptor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Models of crk adaptor proteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Crk adaptor protein-induced phosphorylation of Gab1 on tyrosine 307 via Src is important for organization of focal adhesions and enhanced cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Crk and ABI1: binary molecular switches that regulate abl tyrosine kinase and signaling to the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Crk at the quarter century mark: perspectives in signaling and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Crk and CrkL adaptor proteins: networks for physiological and pathological signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

CrkI and p130(Cas) complex regulates the migration and invasion of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

CrkII induces serum response factor activation and cellular transformation through its function in Rho activation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Crk associates with ERM proteins and promotes cell motility toward hyaluronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

c-Crk proto-oncogene contributes to transcriptional repression of p120-catenin in non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Roles for crk in cancer metastasis and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Emerging roles for crk in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

CRKL promotes cell proliferation in gastric cancer and is negatively regulated by miR-126.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

CrkL efficiently mediates cell proliferation, migration, and invasion induced by TGF-β pathway in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

CrkL plays a role in SDF-1-induced activation of the Raf-1/MEK/Erk pathway through Ras and Rac to mediate chemotactic signaling in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Smad transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Cyclin-dependent kinases regulate the antiproliferative function of Smads

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Analysis of protein-protein interactions in cross-talk pathways reveals CRKL protein as a novel prognostic marker in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Clinical significance and biological roles of CRKL in human bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Regulation of cyclin D1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Midkine confers Adriamycin resistance in human gastric cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: involvement of the p21WAF1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Cyclin D1: polymorphism, aberrant splicing and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Overexpression of CRKL correlates with poor prognosis and cell proliferation in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Cyclin D1 and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Anaplastic lymphoma kinase activates the small GTPase Rap1 via the Rap1-specific GEF C3G in both neuroblastoma and PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

CRKL as a lung cancer oncogene and mediator of acquired resistance to EGFR inhibitors: is it all that it is cracked up to be?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Downregulation of CRKL expression can inhibit tumorigenesis in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Crk and CrkL present with different expression and significance in epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Phosphorylated Crkl reduction levels are associated with the lowest P-glycoprotein activity levels in cells from chronic myeloid leukemia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Overexpression of CRKL correlates with malignant cell proliferation in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

CrkL is a co-activator of estrogen receptor alpha that enhances tumorigenic potential in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

CRKL plays a pivotal role in tumorigenesis of head and neck squamous cell carcinoma through the regulation of cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

The small GTPase, Rap1, mediates CD31-induced integrin adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Loss-of-function screen in rhabdomyosarcoma identifies CRKL-YES as a critical signal for tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

Src-inducible association of CrkL with procaspase-8 promotes cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.14.199

21 January 2018

Identifiers

DOI

10.2217/FON.14.199

1 reference

1 September 2017

1 reference